Skip to main content

Table 2 Number of patients for whom a VTE prophylaxis was prescribed by period of time

From: Venous thromboembolism prophylaxis in patients undergoing abdominal and pelvic cancer surgery: adherence and compliance to ACCP guidelines in DIONYS registry

n (%)

Abdominal (N = 435)

Pelvic (N = 390)

Abdominal + Pelvic (N = 96)

Total (N = 921)

Period of intake

 Before surgery

1 (0.2)

4 (1.0)

0

5 (0.5)

 From surgery to hospital discharge

387 (89.0)

357 (91.5)

85 (88.5)

829 (90.0)

  None

48 (11.0)

33 (8.5)

11 (11.5)

92 (10.0)

  Mechanical only

10 (2.3)

18 (4.6)

0

28 (3.0)

  Pharmacological only

173 (39.8)

149 (38.2)

50 (52.1)

372 (40.4)

  Mechanical + Pharmacological

204 (46.9)

190 (48.7)

35 (36.5)

429 (46.6)

 After hospital discharge

104 (23.9)

126 (32.3)

31 (32.3)

261 (28.3)

  None

331 (76.1)

329 (67.7)

 

660 (71,7)

  Mechanical only

8 (1.8)

44 (9.1)

 

52 (5.6)

  Pharmacological only

90 (20.7)

105 (21.6)

 

195 (21.2)

  Mechanical + Pharmacological

6 (1.4)

8 (1.6)

 

14 (1.5)

 During the whole study (from surgery to post-hospital discharge)

387 (89.0)

360 (92.3)

85 (88.5)

832 (90.3)

  None

48 (11.0)

30 (7.7)

11 (11.5)

89 (9.7)

  Mechanical only

10 (2.3)

18 (4.6)

0

28 (3.0)

  Pharmacological only

173 (39.8)

152 (39.0)

50 (52.1)

375 (40.7)

  Mechanical + Pharmacological

204 (46.9)

190 (48.7)

35 (36.5)

429 (46.6)

  1. VTE venous thromboembolism